CIBC Private Wealth Group’s Axogen AXGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
$18.8K Buy
573
+3
+0.5% +$74 ﹤0.01% 2186
2025
Q3
$10.2K Hold
570
﹤0.01% 2377
2025
Q2
$6.18K Hold
570
﹤0.01% 2413
2025
Q1
$9.07K Buy
570
+500
+714% +$9.02K ﹤0.01% 2273
2024
Q4
$1.07K Sell
70
-90
-56% -$1.27K ﹤0.01% 2791
2024
Q3
$2.24K Hold
160
﹤0.01% 2783
2024
Q2
$1.22K Hold
160
﹤0.01% 2858
2024
Q1
$1.27K Buy
+160
New +$1.43K ﹤0.01% 2834
2019
Q1
Sell
-175,191
Closed -$3.58M 925
2018
Q4
$3.58M Sell
175,191
-461,872
-73% -$14.4M 0.02% 376
2018
Q3
$23.5M Buy
637,063
+383,766
+152% +$16.8M 0.09% 196
2018
Q2
$12.7M Buy
253,297
+22,351
+10% +$985K 0.05% 258
2018
Q1
$8.43M Buy
+230,946
New +$7.08M 0.04% 301

Other funds holding AXGN

CIBC Private Wealth Group's AXGN Position: Q4 2025 in Review

CIBC Private Wealth Group increased its Axogen (AXGN) stake by 0.53% in Q4 2025, buying an estimated $74 and bringing the position to 573 shares worth $18.8K. The position accounts for ﹤0.01% of the portfolio, ranked #2186.

CIBC Private Wealth Group first reported a position in AXGN in Q1 2018 and has held it in 12 quarters since. The position peaked at $23.5M in Q3 2018. 208 funds tracked by Wall St. Rank hold AXGN as of Q4 2025.

  • CIBC Private Wealth Group held 573 shares of Axogen worth $18.8K as of Q4 2025.
  • CIBC Private Wealth Group bought 3 Axogen shares in Q4 2025, an estimated $74.
  • Axogen made up ﹤0.01% of CIBC Private Wealth Group's portfolio in Q4 2025, its #2186 holding.
  • CIBC Private Wealth Group first reported a position in Axogen in Q1 2018 and has held it in 12 quarters since.
  • CIBC Private Wealth Group's Axogen position peaked at $23.5M in Q3 2018.
  • 208 funds tracked by Wall St. Rank held Axogen as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.